Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3' untranslated region, thereby altering RNA conformation

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9110-9116

  Huang, Peiyong ^a   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; GENE DELETION; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RNA CONFORMATION; RNA TRANSCRIPTION; VIRUS GENOME;

EID: 0032853154     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9110-9116.1999     Document Type: Article

References (29)

1. Chang, Y. N., D. J. Kenan, J. D. Keene, A. Gatignol, and K. T. Jeang. 1994. Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J. Virol. 68:7008-7020.
2. Furuya, T., and M. M. C. Lai. 1993. Three different cellular proteins bind to complementary sites on the 5′-end-positive and 3′-end-negative strands of mouse hepatitis virus RNA. J. Virol. 67:7215-7222.
3. Hirano, N., K. Fujiwara, S. Hino, and M. Matsumoto. 1974. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:298-302.
4. Jaeger, J. A., D. H. Turner, and M. Zuker. 1989. Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA 86:7706-7710.
5. Jaeger, J. A., D. H. Turner, and M. Zuker. 1989. Predicting optimal and suboptimal secondary structure for RNA. Methods Enzymol. 183:281-306.
6. Jeong, Y. S., and S. Makino. 1994. Evidence for coronavirus discontinuous transcription. J. Virol. 68:2615-2623.
7. Kramer, A. 1996. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65:367-409.
8. Lai, M. M. C. 1998. Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription. Virology 244:1-12.
9. Lai, M. M. C., P. R. Brayton, R. C. Armen, C. D. Patton, C. Pugh, and S. A. Stohlman. 1981. Mouse hepatitis virus A59: messenger RNA structure and genetic localization of the sequence divergence from the hepatotropic strain MHV 3. J. Virol. 39:823-834.
10. Lai, M. M. C., and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
11. Lai, M. M. C., C. D. Patton, and S. A. Stohlman. 1982. Further characterization of mRNAs of mouse hepatitis virus: presence of common 5′-end nucleotides. J. Virol. 41:557-656.
12. Lai, M. M. C., and S. A. Stohlman. 1978. The RNA of mouse hepatitis virus. J. Virol. 26:236-242.
13. Lee, H.-J., C.-K. Shieh, A. E. Gorbalenya, E. V. Koonin, N. La Monica, J. Tuler, A. Bagdzyahdzhyan, and M. M. C. Lai. 1991. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology 180:567-582.
14. Li, H.-P., P. Huang, S. Park, and M. M. C. Lai. 1999. Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J. Virol. 73:772-777.
15. Li, H.-P., X. Zhang, R. Duncan, L. Comai, and M. M. C. Lai. 1997. Heterogeneous nuclear ribonucleoprotein Al binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc. Natl. Acad. Sci. USA 94:9544-9549.
16. Liao, C.-L., and M. M. C. Lai. 1994. Requirement of the 5′-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J. Virol. 68:4727-4737.
17. Liao, C.-L., X. M. Zhang, and M. M. C. Lai. 1995. Coronavirus defective-interfering RNA as an expression vector: the generation of a pseudorecombinant mouse hepatitis virus expressing hemagglutinin-esterase. Virology 208:319-327.
18. Lin, Y.-J., X. Zhang, R.-C. Wu, and M. M. C. Lai. 1996. The 3′ untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J. Virol. 70:7236-7240.
19. Lin, Y.-J., C.-L. Liao, and M. M. C. Lai. 1994. Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J. Virol. 68:8131-8140.
20. Makino, S., M. Joo, and J. K. Makino. 1991. A system for study of corona-virus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 65:6031-5041.
21. Manaker, R. A., C. V. Piczak, A. A. Miller, and M. F. Stanton. 1961. A hepatitis virus complicating studies with mouse leukemia. J. Natl. Cancer Inst. 27:29-51.
22. Pachuk, C. J., P. J. Bredenbeek, P. W. Zoltick, W. J. M. Spaan, and S. R. Weiss. 1989. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus strain A59. Virology 171:141-148.
23. Pardigon, N., and J. H. Strauss. 1996. Mosquito homolog of the La autoantigen binds to Sindbis virus RNA. J. Virol. 70:1173-1181.
24. Schlegl, J., V. Gegout, B. Schlager, M. W. Hentze, E. Westhof, C. Ehresmann, B. Ehresmann, and P. Romby. 1997. Probing the structure of the regulatory region of human transferring receptor messenger RNA and its interaction with iron regulatory protein-1. RNA 3:1159-1172.
25. Singh, N. K., C. D. Atreya, and H. L. Hakhasi. 1994. Identification of calreticulin as a rubella virus RNA binding protein. Proc. Natl. Acad. Sci. USA 91:12770-12774.
26. Spaan, W. J. M., H. Delius, M. Skinner, J. Armstrong, P. Rottier, S. Smeekens, B. A. M. van der Zeijst, and S. G. Siddell. 1983. Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J. 2:1839-1844.
27. Svitikin, Y. V., A. Pause, and N. Sonenberg. 1994. La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol. 69:7001-7007.
28. Zhang, X., C-L. Liao, and M. M. C. Lai. 1994. Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription, both in trans and in cis. J. Virol. 68:4738-4746.
29. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48-52.